School of Medicine
Showing 1-10 of 98 Results
-
Timur Absalyamov
Affiliate, Medicine - Med/Stanford Prevention Research Center
BioTimur Absalyamov holds a Doctorate in Economics and a Master’s degree in Sports Ethics and Integrity. He has conducted academic research at multiple universities and has gained professional experience working in Russian soccer, as well as an independent sports management consultant.
Throughout his career, he has received several prestigious scholarships and awards, including the Erasmus Mundus Scholarship, Fulbright Scholarship, Sverker Åström Foundation Scholarship, 4x British Petroleum Scholarship, and the Oxford Russia Fund Scholarship. Timur’s areas of expertise include sports ethics, sports and geopolitics, public funding of professional sports, and issues of sports and sustainability. -
Lucia Aronica
Casual Employee, Medicine - Med/Stanford Prevention Research Center
BioFor over seventeen years, my research has focused on the field of epigenetics, examining how environmental factors influence gene expression and health outcomes. Unlike fixed genetic sequences, epigenetic modifications exhibit remarkable flexibility, serving as cellular memory systems that respond to dietary patterns, stress levels, and environmental exposures. This dynamic characteristic creates significant potential for personalized medicine approaches, as epigenetic markers can indicate susceptibility to lifestyle-associated conditions including metabolic disorders, cardiovascular disease, and cancer.
I currently lead the epigenetic analysis component of the DIETFITS study directed by Dr. Christopher Gardner, a landmark clinical trial comparing low-carbohydrate versus low-fat dietary interventions for weight management. My research aims to characterize how sustained weight loss modifies gene activity through epigenetic mechanisms, and whether these molecular signatures might inform individualized nutritional recommendations.
At Stanford, I teach courses in Nutritional Genomics and Epigenetics through Stanford Continuing Studies, Stanford Sports Medicine, and the Stanford Center for Professional Development. My educational approach integrates rigorous scientific evidence with clear explanations of complex biological concepts, making epigenetic science accessible to interdisciplinary audiences.
My scientific contributions include publications in peer-reviewed journals examining the relationship between nutrition, epigenetic modifications, and health outcomes. I also collaborate with academic and industry partners to advance precision health initiatives, serving as a scientific advisor to genomics researchers and technology innovators working at the intersection of epigenetics and personalized health.
My research is guided by the principle that understanding the molecular dialogue between our environment and our genes can transform how we approach health optimization and disease prevention through evidence-based lifestyle interventions. -
Michael Baiocchi
Associate Professor of Epidemiology and Population Health and, by courtesy, of Statistics and of Medicine (Stanford Prevention Research Center)
BioProfessor Baiocchi is a PhD statistician in Stanford University's Epidemiology and Population Health Department. He thinks a lot about behavioral interventions and how to rigorously evaluate if and how they work. Methodologically, his work focuses on creating statistically rigorous methods for causal inference that are transparent and easy to critique. He designed -- and was the principle investigator for -- two large randomized studies of interventions to prevent sexual assault in the settlements of Nairobi, Kenya.
Professor Baiocchi is an interventional statistician (i.e., grounded in both the creation and evaluation of interventions). The unifying idea in his research is that he brings rigorous, quantitative approaches to bear upon messy, real-world questions to better people's lives. -
Narges Baniasadi
Academic Staff - Hourly - CSL, Medicine - Stanford Prevention Research Center
BioDr. Narges Baniasadi is founder and executive director of Emergence program at Stanford. She develops educational and translational programs for improving societal health through entrepreneurship. She is also Adjunct Professor with the Department of Medicine where she teaches impact entrepreneurship in the areas related to Prevention and Health Equity. Narges has led multiple initiatives and businesses in the intersection of Technology and Life Sciences for more than a decade. She founded Bina, a pioneering Bioinformatics company, out of a decade of research at Stanford and UC Berkeley. Bina developed high performance computing platforms and AI solutions for cancer research and genomics analysis. Later, upon acquisition of Bina by Roche, she led the clinical software development and AI research as VP of Informatics at Roche Sequencing until 2018.
